Viewing Study NCT01557959


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-26 @ 11:38 PM
Study NCT ID: NCT01557959
Status: COMPLETED
Last Update Posted: 2018-06-29
First Post: 2012-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Wake Forest University Health Sciences
Organization: